Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Metastases in Subjects With Advanced Cancer”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Early research (Phase 1)Looking for participantsNCT07087197
What this trial is testing

SKB107 in Advanced Solid Tumors With Bone Metastases

Who this might be right for
Metastatic Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06805396
What this trial is testing

Timely Integration of Palliative Care in Oncology Care for Patients Referred for Palliative Radiotherapy on Bone Metastases: a Randomized Trial

Who this might be right for
Bone Metastases in Subjects with Advanced CancerRadiotherapy
Roxanne Gal 246
Early research (Phase 1)Looking for participantsNCT06069570
What this trial is testing

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

Who this might be right for
Carcinoma, Non-Small-Cell Lung CancerBone Metastases From Solid Tumors
Kiromic BioPharma Inc. 48
Early research (Phase 1)Study completedNCT02160106
What this trial is testing

First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors

Who this might be right for
Advanced Stage Solid Tumors
MedPacto, Inc. 35
Large-scale testing (Phase 3)Study completedNCT01419717
What this trial is testing

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

Who this might be right for
Bone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast Cancer
Amgen 129
Early research (Phase 1)Looking for participantsNCT07197645
What this trial is testing

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Who this might be right for
Bone PainMetastatic Bone TumorBone Metastases in Subjects With Advanced Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 33
Early research (Phase 1)Ended earlyNCT03525392
What this trial is testing

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerGastric Cancer+5 more
Ipsen 14
Not applicableLooking for participantsNCT07171996
What this trial is testing

Research on the Optimization of Treatment for Spinal Metastases With Radioactive Particle Implantation Using TPS and Mechanical Dual Simulation

Who this might be right for
Bone Metastases in Subjects With Advanced Cancer
Li Min 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07249892
What this trial is testing

BPR-6023021 in Advanced Solid Tumors With Bone Metastases

Who this might be right for
Metastatic Solid Tumors
Chengdu Syncor Pharmaceutical Co., Ltd. 195
Not applicableLooking for participantsNCT06987370
What this trial is testing

SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue

Who this might be right for
Bone Metastases in Subjects With Advanced Cancer
Shandong Cancer Hospital and Institute 90
Testing effectiveness (Phase 2)Study completedNCT00104650
What this trial is testing

Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates

Who this might be right for
Bone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast CancerBone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
Amgen 111
Testing effectiveness (Phase 2)UnknownNCT04325776
What this trial is testing

AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

Who this might be right for
Bone Metastatic Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT00321464
What this trial is testing

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Who this might be right for
Bone Metastases
Amgen 2,049
Testing effectiveness (Phase 2)Study completedNCT00091832
What this trial is testing

Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastasesBone Metastases in Subjects With Advanced Breast Cancer
Amgen 255
Large-scale testing (Phase 3)Study completedNCT00330759
What this trial is testing

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Who this might be right for
Bone Metastases
Amgen 1,779
Large-scale testing (Phase 3)Study completedNCT00950911
What this trial is testing

Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only

Who this might be right for
Bone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast CancerBone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
Amgen 35